Trials / Recruiting
RecruitingNCT06937034
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
Observational Retrospective CoHort Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Main objective of this study is to describe the evolution of infusion settings (base, high and low infusion rates) of foslevodopa/foscarbidopa subcutaneous infusion (LDp/CDp) at different timepoints in the treatment of advanced Parkinson's disease (aPD) as captured in ONE-CRM.
Conditions
Timeline
- Start date
- 2025-04-14
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-04-20
- Last updated
- 2025-08-05
Locations
4 sites across 4 countries: Austria, Netherlands, Romania, Sweden
Source: ClinicalTrials.gov record NCT06937034. Inclusion in this directory is not an endorsement.